Karyopharm Therapeutics Cash from Investing (TTM) Insights

Karyopharm Therapeutics Inc (KPTI)

1.275 -0.10 (-7.61%) USD | NASDAQ | Apr 18, 16:00

1.27 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	7.94M
September 30, 2023	-84.20M
June 30, 2023	-64.84M
March 31, 2023	-122.61M
December 31, 2022	-104.26M
September 30, 2022	-8.188M
June 30, 2022	1.565M
March 31, 2022	84.62M
December 31, 2021	141.84M
September 30, 2021	142.47M
June 30, 2021	142.47M
March 31, 2021	35.98M
December 31, 2020	-53.68M
September 30, 2020	-118.60M
June 30, 2020	-99.86M
March 31, 2020	-0.02M
December 31, 2019	78.45M
September 30, 2019	8.859M
June 30, 2019	-10.75M
March 31, 2019	-78.16M
December 31, 2018	-107.66M

Date	Value
September 30, 2018	-7.455M
June 30, 2018	-7.427M
March 31, 2018	19.04M
December 31, 2017	17.11M
September 30, 2017	26.61M
June 30, 2017	1.042M
March 31, 2017	18.39M
December 31, 2016	24.60M
September 30, 2016	51.84M
June 30, 2016	101.37M
March 31, 2016	86.01M
December 31, 2015	-90.82M
September 30, 2015	-188.56M
June 30, 2015	-235.40M
March 31, 2015	-236.59M
December 31, 2014	-67.03M
September 30, 2014	-3.167M
June 30, 2014	-0.906M
March 31, 2014	-0.582M
December 31, 2013	-0.057M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-122.61M

Minimum

Mar 2023

142.47M

Maximum

Jun 2021

-1.201M

Average

-0.02M

Median

Mar 2020

Cash from Investing (TTM) Benchmarks